Relevant bibliographies by topics / Person Level Model of Pharmaceutical Benefits

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Conference papers

Academic literature on the topic 'Person Level Model of Pharmaceutical Benefits'

Author: Grafiati
Published: 4 June 2021
Last updated: 2 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Person Level Model of Pharmaceutical Benefits.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Person Level Model of Pharmaceutical Benefits"

1

Soller, Jeffrey A. "The potential implications of person-to-person transmission of viral infection for US EPA's Groundwater Rule." Journal of Water and Health 7, no. 2 (2009): 208–23. http://dx.doi.org/10.2166/wh.2009.118.

Full text
Abstract:
The risk characterization method employed by US EPA to quantitatively characterize the benefits of the Groundwater Rule (GWR) for drinking water computes person-to-person transmission intensity as the product of the number of primary illnesses and a static secondary morbidity factor. A population level infectious disease health effects model is used here to evaluate the implications of secondary transmission on exposures to viruses that are relevant to the GWR. These implications are evaluated via a hypothetical case study in which it is assumed that a tour group from a large population centre
APA, Harvard, Vancouver, ISO, and other styles
2

Hornke, Lutz F. "Benefits from Computerized Adaptive Testing as Seen in Simulation Studies." European Journal of Psychological Assessment 15, no. 2 (1999): 91–98. http://dx.doi.org/10.1027//1015-5759.15.2.91.

Full text
Abstract:
Summary: Item parameters for several hundreds of items were estimated based on empirical data from several thousands of subjects. The logistic one-parameter (1PL) and two-parameter (2PL) model estimates were evaluated. However, model fit showed that only a subset of items complied sufficiently, so that the remaining ones were assembled in well-fitting item banks. In several simulation studies 5000 simulated responses were generated in accordance with a computerized adaptive test procedure along with person parameters. A general reliability of .80 or a standard error of measurement of .44 was u
APA, Harvard, Vancouver, ISO, and other styles
3

Walker, Agnes. "Distributional impact of higher patient contributions to Australia's Pharmaceutical Benefits Scheme." Australian Health Review 23, no. 2 (2000): 32. http://dx.doi.org/10.1071/ah000032.

Full text
Abstract:
This paper uses NATSEM's Pharmaceutical Benefits Model to analyse the effects of a hypothetical25 per cent rise in patient contributions to prescribed medicines under Australia's PharmaceuticalBenefits Scheme (PBS). The model, based on microsimulation techniques, is able to provide a muchbroader range of outcomes information, at a much greater level of detail, than is possible withtraditional methods.Higher patient contributions are analysed in terms of their impact on the government to patient splitin PBS costs, as well as the distribution of such costs across age groups, family incomes, fami
APA, Harvard, Vancouver, ISO, and other styles
4

Mudimu, Edinah, Kathryn Peebles, Zindoga Mukandavire, et al. "Individual and community-level benefits of PrEP in western Kenya and South Africa: Implications for population prioritization of PrEP provision." PLOS ONE 15, no. 12 (2020): e0244761. http://dx.doi.org/10.1371/journal.pone.0244761.

Full text
Abstract:
Background Pre-exposure prophylaxis (PrEP) is highly effective in preventing HIV and has the potential to significantly impact the HIV epidemic. Given limited resources for HIV prevention, identifying PrEP provision strategies that maximize impact is critical. Methods We used a stochastic individual-based network model to evaluate the direct (infections prevented among PrEP users) and indirect (infections prevented among non-PrEP users as a result of PrEP) benefits of PrEP, the person-years of PrEP required to prevent one HIV infection, and the community-level impact of providing PrEP to popul
APA, Harvard, Vancouver, ISO, and other styles
5

Dong, Xiaojing, Puneet Manchanda, and Pradeep K. Chintagunta. "Quantifying the Benefits of Individual-Level Targeting in the Presence of Firm Strategic Behavior." Journal of Marketing Research 46, no. 2 (2009): 207–21. http://dx.doi.org/10.1509/jmkr.46.2.207.

Full text
Abstract:
The authors develop a method to quantify the benefits of individual-level targeting when the data reflect firm strategic behavior—that is, when firms (1) are engaged in targeting and (2) take into account the actions of competing firms. This article studies a pharmaceutical firm's decision on the allocation of detailing visits across individual physicians. For this analysis, the authors develop, at the individual level, a model of prescriptions and a model of detailing. Using physician panel data, they estimate, at the physician level, the parameters of the prescription and detailing models jo
APA, Harvard, Vancouver, ISO, and other styles
6

Yu, Wenguang, Bing Li, and Xianghan Zhu. "Income Redistribution Effect of Raising the Overall Planning Level of Basic Endowment Insurance for Urban Employees in China." Sustainability 13, no. 2 (2021): 709. http://dx.doi.org/10.3390/su13020709.

Full text
Abstract:
It is the focus of social security system reform at this stage in China to promote the transition of basic endowment insurance for urban employees from provincial overall planning level to national overall planning level, which is of great significance to the realization of fair and efficient of economic development. Based on the micro data of China Household Finance Survey 2017 (CHFS2017), this paper first establishes a personal wage prediction model to estimate the distribution of personal lifetime wage income, then designs two pension collection and payment plans of “direct national overall
APA, Harvard, Vancouver, ISO, and other styles
7

Bungard, Tammy J., Stephen L. Archer, Peter Hamilton, Bruce Ritchie, Wayne Tymchak, and Ross T. Tsuyuki. "Bringing the Benefits of Anticoagulation Management Services to the Community." Canadian Pharmacists Journal / Revue des Pharmaciens du Canada 139, no. 2 (2006): 58–64. http://dx.doi.org/10.1177/171516350613900207.

Full text
Abstract:
Background: While warfarin is efficacious for the prevention of thromboembolic disorders, many patients are undertreated. To optimize therapy, anticoagulation management services (AMSs) deliver a coordinated, focused approach to this care; however, AMSs are limited in their ability to impact patients outside of tertiary care settings. Objective: To describe the methods used to develop community-based AMSs across Alberta. Methods: Through a three-staged approach, this project created community-based, pharmacist-managed AMSs for patients requiring warfarin therapy. Stage I was the initiation of
APA, Harvard, Vancouver, ISO, and other styles
8

Liu, Wan-Yu, Bo-Sheng Fang, and Chi-Ming Hsieh. "Evaluating the Recreation Value of Alishan National Forest Recreation Area in Taiwan." Forests 12, no. 9 (2021): 1245. http://dx.doi.org/10.3390/f12091245.

Full text
Abstract:
This study aimed to construct an effective model to estimate the recreation value and total annual recreation benefits of the Alishan National Forest Recreation Area (ANFR) through the travel cost method. Negative binomial regression was also employed to estimate the demand function. This study sorted participants based on gender, age, level of education, personal monthly income, occupation, and place of residence to examine their differences in perceived recreation value and recreation demand. The survey responses revealed that most tourists were mainly middle aged, and took family vacations.
APA, Harvard, Vancouver, ISO, and other styles
9

Marra, Carlo, Karissa Johnston, Valerie Santschi, and Ross T. Tsuyuki. "Cost-effectiveness of pharmacist care for managing hypertension in Canada." Canadian Pharmacists Journal / Revue des Pharmaciens du Canada 150, no. 3 (2017): 184–97. http://dx.doi.org/10.1177/1715163517701109.

Full text
Abstract:
Background: More than half of all heart disease and stroke are attributable to hypertension, which is associated with approximately 10% of direct medical costs globally. Clinical trial evidence has demonstrated that the benefits of pharmacist intervention, including education, consultation and/or prescribing, can help to reduce blood pressure; a recent Canadian trial found an 18.3 mmHg reduction in systolic blood pressure associated with pharmacist care and prescribing. The objective of this study was to evaluate the economic impact of such an intervention in a Canadian setting. Methods: A Mar
APA, Harvard, Vancouver, ISO, and other styles
10

Scobee, Shari P., Michael DuRoss, and Edward C. Ratledge. "Development of Trip Production Rates for Synthesized Households." Transportation Research Record: Journal of the Transportation Research Board 1625, no. 1 (1998): 79–85. http://dx.doi.org/10.3141/1625-10.

Full text
Abstract:
Survey nonresponse bias is an important consideration in the development of survey designs for transportation studies. Researchers at the University of Delaware have developed a technique for reducing the survey nonresponse, as well as the cost of the travel survey. The method involves obtaining complete household and person characteristics for each household member; however, detailed travel data are gathered for only one randomly selected household member. Although the University of Delaware survey technique provides multiple benefits with respect to survey response rates and costs, it presen
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Person Level Model of Pharmaceutical Benefits"

1

Schofield, Deborah, and n/a. "Modelling health care expenditure : a new microsimulation approach to simulating the distributional impact of the Pharmaceutical Benefits Scheme." University of Canberra. Information Sciences & Engineering, 1999. http://erl.canberra.edu.au./public/adt-AUC20061107.171802.

Full text
Abstract:
In this thesis, a microsimulation model was developed using methods which were intended to overcome the main criticism of earlier models developed in Australia - that their estimation of the distribution of health benefits1 across income groups was not accurate. To determine whether the new model � called the Person Level Model of Pharmaceutical Benefits (PLM-PB) � was more accurate, two typical means-based models were also built to replicate the most commonly used methods in Australia. A comparison of the results of the three models revealed that while they produced comparable results at the
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Person Level Model of Pharmaceutical Benefits"

1

Karamchetty, Somayajulu D. "Hierarchical Engineering Model of the Human Body." In ASME 2016 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2016. http://dx.doi.org/10.1115/imece2016-66253.

Full text
Abstract:
Engineers and scientists are able to understand and analyze the behavior of complex engineering systems in a wide range of critical technologies through hierarchical modeling followed by simulation of the model operation. This process results in a high fidelity integrated model as each level in the hierarchy is modeled in sufficient detail. The overall objective of this effort is to develop a sophisticated hierarchical model of the human body, followed by simulation of the model operation. In this initial research phase, the feasibility of the concept is explored and a framework for the model
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Person Level Model of Pharmaceutical Benefits' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography